Hannah Maynard

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

Maeve A. Lowery, Winston Wong, Emmet Jordan et al. · JNCI Journal of the National Cancer Institute · 2018 · 224 citations · Full text

Medicine, Genetics, Oncology +17

Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype

Maeve A. Lowery, Emmet Jordan, Olca Baştürk et al. · Clinical Cancer Research · 2017 · 212 citations

Medicine, Molecular Genetics, Oncology +16

Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma

Maeve A. Lowery, David P. Kelsen, Marinela Capanu et al. · European Journal of Cancer · 2017 · 151 citations · Full text

Medicine, Oncology, Chemotherapy +8

Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline <i>BRCA</i> mutation carriers and wild‐type <i>BRCA</i> pancreatic ductal adenocarcinoma

Eileen M. O’Reilly, Jonathan W. Lee, Maeve A. Lowery et al. · Cancer · 2018 · 103 citations

Medicine, Oncology, Pharmacology +12

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

Talia Golan, Tal Sella, Eileen M. O’Reilly et al. · British Journal of Cancer · 2017 · 85 citations · Full text

Medicine, Oncology, Surgery +16